Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet NOVOSEVEN 2.4mg (120KUI) powder and solution for solution for injection
- Product code:
- W52382001
- Quantity:
- 1
- Indicated for:
- bleeding; coagulation disorders
- Route of administration:
- injectable
- Substance:
- eptacog alpha activated (anticoagulant)
- ATC
- B02BD08 — Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Precautions:
Major drug interactions
This medicine may have important interactions with other medicines.
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Bleeding risk
This medicine may increase the risk of bleeding.
Eptacog alfa activated is a medication used to control and prevent bleeding in patients with hemophilia A or B with inhibitors, as well as in other rare coagulation disorders. It works by stimulating the formation of blood clots, helping to quickly stop bleeding.
It is administered intravenously under strict medical supervision, with the dose adjusted according to the severity of the bleeding and the patient's response.
Side effects may include injection site reactions, fever, headaches, increased risk of thrombosis, or, rarely, severe allergic reactions. Careful monitoring is necessary throughout the treatment.
Eptacog alfa activated is an essential option for patients with coagulation disorders, offering the chance to effectively control bleeding episodes and prevent serious complications.
It is administered intravenously under strict medical supervision, with the dose adjusted according to the severity of the bleeding and the patient's response.
Side effects may include injection site reactions, fever, headaches, increased risk of thrombosis, or, rarely, severe allergic reactions. Careful monitoring is necessary throughout the treatment.
Eptacog alfa activated is an essential option for patients with coagulation disorders, offering the chance to effectively control bleeding episodes and prevent serious complications.
General data about NOVOSEVEN 2.4mg (120KUI)
- Substance:
- eptacog alpha activated
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W52382001
- Concentration:
- 120KUI
- Pharmaceutical form:
- powder and solution for solution for injection
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for eptacog alpha activated
Concentrations available for eptacog alpha activated
- 100KUI
- 120KUI
- 240 KUI
- 250KUI
- 50KUI
- 60KUI